Skip to content
healthcare.dev

Tadalafil

NDC 67184-0525, Tadalafil, tablet, film coated, from Qilu Pharmaceutical Co., Ltd..

Product NDC
67184-0525
Status
Listed
Labeler
Qilu Pharmaceutical Co., Ltd.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210420
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0525 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TADALAFIL10 mg/1

Pharmacologic classes

Phosphodiesterase 5 Inhibitor [EPC]; Phosphodiesterase 5 Inhibitors [MoA]

Package NDCNDC-11Package
67184-0525-2671840525021 BLISTER PACK in 1 CARTON (67184-0525-2) / 7 TABLET, FILM COATED in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f295f164-78fb-4224-b319-9f20b7a453b5

Use it

Look up 67184-0525 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0525 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67184-0525. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.